Arsanik Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-12-2024
- Paid Up Capital ₹ 1.00 M
as on 24-12-2024
- Company Age 11 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.70 M
as on 24-12-2024
- Satisfied Charges ₹ 6.82 M
as on 24-12-2024
- Revenue -18.59%
(FY 2020)
- Profit -22.24%
(FY 2020)
- Ebitda -19.97%
(FY 2020)
- Net Worth 21.82%
(FY 2020)
- Total Assets -9.69%
(FY 2020)
About Arsanik Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.70 M. The company has closed loans amounting to ₹6.82 M, as per Ministry of Corporate Affairs (MCA) records.
Surekha Talekar, Padmaja Rao, and Ganapatrao Talekar serve as directors at the Company.
- CIN/LLPIN
U33111GA2014PTC007403
- Company No.
007403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arsanik Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surekha Talekar  | Director | 15-Jan-2014 | Current |
| Padmaja Rao | Director | 06-Nov-2023 | Current |
| Ganapatrao Talekar | Director | 16-Jun-2016 | Current |
Financial Performance of Arsanik Healthcare.
Arsanik Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 18.59% decrease. The company also saw a substantial fall in profitability, with a 22.24% decrease in profit. The company's net worth Soared by an impressive increase of 21.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arsanik Healthcare?
In 2020, Arsanik Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.70 M
₹6.82 M
Charges Breakdown by Lending Institutions
- Others : 0.67 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2021 | Others | ₹0.96 M | Open |
| 29 Sep 2018 | Others | ₹0.94 M | Open |
| 15 Feb 2017 | Others | ₹4.80 M | Open |
| 29 May 2020 | Others | ₹1.58 M | Satisfied |
| 20 Sep 2019 | Others | ₹1.21 M | Satisfied |
How Many Employees Work at Arsanik Healthcare?
Unlock and access historical data on people associated with Arsanik Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arsanik Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arsanik Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
